Non-inquiry session · Opened 8 January 2025

The work of NHS England

From: Health and Social Care Committee

Open3 documents4 evidence sessions

What this inquiry is asking

This inquiry examines NHS England's operational performance and the government's plan to abolish it as a separate organisation and merge it with the Department of Health and Social Care. The committee is investigating whether the restructuring will improve patient outcomes, how the 50% headcount cut will affect services, and whether financial sustainability can be achieved without harming frontline care.

Status / emerging findings

  • NHS England claims financial stability achieved in first half of 2025-26 despite earlier £6.7bn deficit projection, but redundancy savings (~£500m annually) remain subject to Treasury negotiation.
  • Mental health spending rising in cash terms (£15.6bn for 2025-26) but falling as proportion of overall NHS budget by 0.07%—first proportional decrease since 2018, contradicting parity of esteem commitments.
  • Patient safety risks flagged: previous NHS reorganisations caused loss of institutional memory; ongoing initiatives (Martha's rule, valproate/mesh work) risk disruption during transition.
  • Health inequalities threatened by recruitment freezes and funding cuts in VCSE sector affecting vulnerable populations; concern that moving LGBTQ health functions politicises rather than evidence-bases specialist care.
  • Secretary of State acknowledged making mental health overdiagnosis claims without comprehensive prior evidence; cited prescription rises and BBC Panorama but chair challenged whether this represents reactive positioning rather than policy rigour.

Why it matters

The NHS England merger is one of the largest NHS restructuring since 2013; how it executes will determine whether hundreds of millions can be freed for frontline care or whether service disruption and loss of expertise actually harm patient safety and access.

Tone arc

Inquiry opened procedurally in January 2025 with NHS England defending progress on the 'three shifts' strategy; shifted markedly critical in March when patient safety and workforce leaders testified to risks of reorganisation; by April, focused sharply on government accountability for mental health parity claims and whether structural change serves patients or bureaucracy; September session showed mixed picture—financial stabilisation claims offered against ongoing uncertainty over transition costs and redundancy scale.

Themes

nhs-structural-reformpatient-safety-riskmental-health-parityfinancial-sustainabilityhealth-inequalities

Key witnesses

Sir Jim Mackey, CEO NHS England, Wes Streeting, Secretary of State for Health, Sir Chris Whitty, Chief Medical Officer and Interim Permanent Secretary DHSC, Amanda Pritchard, former CEO NHS England, Dr Claire Fuller, National Medical Director NHS England, Patient Safety Commissioner, VCSE sector representatives (homelessness, mental health, trans healthcare services), Duncan Burton, Chief Nursing Officer NHS England

Witness sessions

Written evidence & correspondence

Themes & actors

Source · parliament.uk inquiry record ↗